RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Liquidia Technologies today announced that it will highlight the diverse capabilities of the company’s PRINT® (Particle Replication In Non-Wetting Templates) technology in vaccine development at the 15th World Vaccines Congress being held at the Walter E. Washington Convention Center in Washington, DC from April 7 – 9, 2015. Dr. Michele Stone, Executive Director of Vaccines at Liquidia, will be presenting Utilizing PRINT Technology to Advance Vacci
| < Prev | Next > |
|---|
